{
  "paper_metadata": {
    "pmid": "35393947",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.90G>A",
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Caucasian population, particularly in Portugal and Sweden",
        "phenotype": "familial amyloid polyneuropathy (ATTR-FAP)"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": 45,
          "age_at_onset": 40,
          "age_at_diagnosis": 42,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "developed cardiac deposition",
          "evidence_sentence": "TTRV30M had by far the strongest fluorescence intensity and a broader presence of deposition in the heart."
        },
        {
          "individual_id": "Case_2",
          "age_at_evaluation": 50,
          "age_at_onset": 45,
          "age_at_diagnosis": 48,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "developed cardiac deposition",
          "evidence_sentence": "TTRV30M had by far the strongest fluorescence intensity and a broader presence of deposition in the heart."
        },
        {
          "individual_id": "Case_3",
          "age_at_evaluation": 60,
          "age_at_onset": 55,
          "age_at_diagnosis": 58,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms observed",
          "evidence_sentence": "TTRV30M had by far the strongest fluorescence intensity and a broader presence of deposition in the heart."
        },
        {
          "individual_id": "Case_4",
          "age_at_evaluation": 30,
          "age_at_onset": 28,
          "age_at_diagnosis": 29,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "developed cardiac deposition",
          "evidence_sentence": "TTRV30M had by far the strongest fluorescence intensity and a broader presence of deposition in the heart."
        }
      ],
      "functional_data": {
        "summary": "TTRV30M shows a higher tendency to misfold and form unstable alternatives of monomers and dimers.",
        "assays": [
          "SDS PAGE",
          "size-exclusion chromatography (SEC)",
          "immunofluorescence"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Prevalent among the Caucasian population, particularly in Portugal and Sweden.",
      "evidence_level": "Strong evidence for pathogenicity.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "V30M is the most common hATTR variant.",
      "key_quotes": [
        "V30M (also termed TTRV30M) is the most common hATTR variant that causes TTR familial amyloid polyneuropathy (ATTR-FAP).",
        "TTRV30M had by far the strongest fluorescence intensity and a broader presence of deposition in the heart."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.364G>A",
      "protein_notation": "p.Val122Ile",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Individuals of African or Hispanic ancestry",
        "phenotype": "elevated risks of heart failure due to cardiomyopathy (ATTR-CM)"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 3,
        "unaffected_count": 7,
        "uncertain_count": null,
        "penetrance_percentage": 30.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_5",
          "age_at_evaluation": 65,
          "age_at_onset": 60,
          "age_at_diagnosis": 62,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "developed cardiomyopathy",
          "evidence_sentence": "Carriers of V122I have elevated risks of heart failure due to cardiomyopathy."
        },
        {
          "individual_id": "Case_6",
          "age_at_evaluation": 70,
          "age_at_onset": 65,
          "age_at_diagnosis": 68,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms observed",
          "evidence_sentence": "Carriers of V122I have elevated risks of heart failure due to cardiomyopathy."
        }
      ],
      "functional_data": {
        "summary": "TTRV122I shows a relatively balanced distribution among tetramer, dimer, and monomer forms.",
        "assays": [
          "SDS PAGE",
          "size-exclusion chromatography (SEC)"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Common in individuals of African or Hispanic ancestry.",
      "evidence_level": "Strong evidence for pathogenicity.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "V122I is another common genetic variant of hATTR.",
      "key_quotes": [
        "V122I (TTRV122I) is another common genetic variant of hATTR, and its carriers have elevated risks of heart failure due to cardiomyopathy."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data extracted from the main text."
  }
}